Anticancer drugs including the chemical structures of an androgen receptor ligand and a histone deacetylase inhibitor
Abstract:
A novel class of drugs for treating androgen receptor (AR) positive cancer including prostate cancer and breast cancer are described. The drugs include the chemical scaffolds of a high affinity androgen receptor ligand and a histone deacetylase inhibitor. Also described are compositions including the novel drugs and methods of treating AR positive cancer using the compositions.
Information query
Patent Agency Ranking
0/0